Is Checkpoint Therapeutics, Inc. (CKPT) a Buy, Sell, or Hold?
Checkpoint Therapeutics, Inc.
NASDAQ:CKPT
$4.26 USD
$0 (0.0%)
- Volume
- 8.63M
- Average Volume
- 3.08M
- Market Capitalization
- $367.72M
- P/E Ratio
- -3.00
- Dividend Yield
- 0.00%
- Price Target
- $4.10
- Year High
- $4.50
- Year Low
- $1.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.37
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
21
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
17
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 8.24M
CKPT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CKPT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10 percent owner | 2025-05-29 | S-Sale | 1.29 | 2025-06-03 |
| Fortress Biotech, Inc. | 10 percent owner | 2025-05-30 | D-Return | 4.1 | 2025-06-03 |
| Fortress Biotech, Inc. | 10 percent owner | 2025-05-30 | D-Return | 4.1 | 2025-06-03 |
| WEISS MICHAEL S | director | 2025-05-29 | A-Award | 1.29 | 2025-05-30 |
| WEISS MICHAEL S | director | 2025-05-28 | A-Award | 0 | 2025-05-30 |
| WEISS MICHAEL S | director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| SALZMAN BARRY M | director | 2025-05-28 | A-Award | 0 | 2025-05-30 |
| SALZMAN BARRY M | director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| ROSENWALD LINDSAY A MD | director | 2025-05-29 | A-Award | 1.29 | 2025-05-30 |
| ROSENWALD LINDSAY A MD | director | 2025-05-28 | A-Award | 0 | 2025-05-30 |
| ROSENWALD LINDSAY A MD | director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| Oliviero James F III | director, officer: CEO, President and Director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| Herskowitz Neil | director | 2025-05-28 | A-Award | 0 | 2025-05-30 |
| Herskowitz Neil | director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| Bechon Christian | director | 2025-05-28 | A-Award | 0 | 2025-05-30 |
| Bechon Christian | director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| Amit Sharma | director | 2025-05-28 | A-Award | 0 | 2025-05-30 |
| Amit Sharma | director | 2025-05-30 | U-Tender | 4.1 | 2025-05-30 |
| Oliviero James F III | director, officer: CEO, President and Director | 2025-04-02 | S-Sale | 4.04 | 2025-04-03 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2025-04-01 | S-Sale | 4.05 | 2025-04-03 |
| Fortress Biotech, Inc. | 10 percent owner | 2025-02-26 | A-Award | 0 | 2025-02-27 |
| Oliviero James F III | director, officer: CEO, President and Director | 2025-02-07 | S-Sale | 3.41 | 2025-02-11 |
| Oliviero James F III | director, officer: CEO, President and Director | 2025-02-10 | S-Sale | 3.15 | 2025-02-11 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2025-02-06 | S-Sale | 3.67 | 2025-02-07 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Oliviero James F III | director, officer: CEO, President and Director | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Fortress Biotech, Inc. | 10 percent owner | 2025-01-01 | A-Award | 0 | 2025-01-03 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-12-31 | A-Award | 0 | 2025-01-03 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-12-18 | S-Sale | 3.87 | 2024-12-20 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-12-19 | S-Sale | 3.38 | 2024-12-20 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-12-20 | G-Gift | 0 | 2024-12-20 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2024-12-18 | S-Sale | 4.01 | 2024-12-20 |
| WEISS MICHAEL S | director | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| SALZMAN BARRY M | director | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| ROSENWALD LINDSAY A MD | director | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| Bechon Christian | director | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| Herskowitz Neil | director | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-09-27 | A-Award | 0 | 2024-10-01 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-06-26 | S-Sale | 2.05 | 2024-06-28 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-06-26 | G-Gift | 0 | 2024-06-28 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2024-06-26 | S-Sale | 2.06 | 2024-06-28 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2024-05-24 | A-Award | 0 | 2024-05-24 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-05-24 | A-Award | 0 | 2024-05-24 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-05-16 | 0 | 2024-05-24 | |
| Fortress Biotech, Inc. | 10 percent owner | 2024-05-16 | 0 | 2024-05-24 | |
| WEISS MICHAEL S | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| WEISS MICHAEL S | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| Amit Sharma | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| SALZMAN BARRY M | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| SALZMAN BARRY M | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| ROSENWALD LINDSAY A MD | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| ROSENWALD LINDSAY A MD | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| Herskowitz Neil | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| Herskowitz Neil | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| Bechon Christian | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| Bechon Christian | director | 2024-05-14 | A-Award | 0 | 2024-05-16 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-03-20 | A-Award | 0 | 2024-03-22 |
| Amit Sharma | director | 2024-03-12 | 0 | 2024-03-19 | |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-02-28 | S-Sale | 2.06 | 2024-03-01 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-02-28 | G-Gift | 0 | 2024-03-01 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2024-02-28 | S-Sale | 2.07 | 2024-03-01 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2024-02-01 | S-Sale | 1.95 | 2024-02-02 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-02-01 | S-Sale | 2.01 | 2024-02-02 |
| Oliviero James F III | director, officer: CEO, President and Director | 2024-02-01 | G-Gift | 0 | 2024-02-02 |
| Oliviero James F III | director, officer: CEO, President and Director | 2023-12-31 | 0 | 2024-02-02 | |
| Fortress Biotech, Inc. | 10 percent owner | 2023-12-29 | A-Award | 0 | 2024-01-03 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-09-25 | A-Award | 0 | 2023-09-26 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| WEISS MICHAEL S | director | 2023-06-13 | A-Award | 0 | 2023-06-15 |
| SALZMAN BARRY M | director | 2023-06-13 | A-Award | 0 | 2023-06-15 |
| ROSENWALD LINDSAY A MD | director | 2023-06-13 | A-Award | 0 | 2023-06-15 |
| Herskowitz Neil | director | 2023-06-13 | A-Award | 0 | 2023-06-15 |
| Boilen Scott | director | 2023-06-13 | A-Award | 0 | 2023-06-15 |
| Bechon Christian | director | 2023-06-13 | A-Award | 0 | 2023-06-15 |
| Oliviero James F III | director, officer: CEO, President and Director | 2023-03-31 | A-Award | 0 | 2023-04-04 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2023-03-31 | A-Award | 0 | 2023-04-04 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-04-04 | A-Award | 0 | 2023-04-04 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-03-31 | A-Award | 0 | 2023-04-04 |
| Oliviero James F III | director, officer: CEO, President and Director | 2023-02-27 | A-Award | 0 | 2023-03-03 |
| Oliviero James F III | director, officer: CEO, President and Director | 2023-03-02 | S-Sale | 5 | 2023-03-03 |
| Oliviero James F III | director, officer: CEO, President and Director | 2023-02-27 | S-Sale | 4.65 | 2023-03-03 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2023-02-27 | A-Award | 0 | 2023-03-03 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2023-03-02 | S-Sale | 5 | 2023-03-03 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2023-02-27 | S-Sale | 4.66 | 2023-03-03 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2023-02-01 | S-Sale | 4.79 | 2023-02-03 |
| Oliviero James F III | director, officer: CEO, President and Director | 2023-02-01 | S-Sale | 4.77 | 2023-02-03 |
| GRAY WILLIAM GARRETT | officer: Chief Financial Officer | 2023-01-10 | S-Sale | 6.749 | 2023-01-12 |
| Oliviero James F III | officer: CEO, President and Director | 2023-01-10 | S-Sale | 6.749 | 2023-01-12 |
| Oliviero James F III | director, officer: CEO, President and Director | 2022-12-31 | 0 | 2023-01-12 | |
| Fortress Biotech, Inc. | director | 2023-01-05 | A-Award | 0 | 2023-01-06 |
| Oliviero James F III | director, officer: CEO, President and Director | 2022-06-17 | S-Sale | 1.09 | 2022-07-01 |
| Oliviero James F III | director, officer: CEO, President and Director | 2022-06-21 | S-Sale | 1.09 | 2022-07-01 |
| Oliviero James F III | director, officer: CEO, President and Director | 2022-06-22 | S-Sale | 1.09 | 2022-07-01 |
| Oliviero James F III | officer: CEO, President and Director | 2022-06-17 | S-Sale | 1.11 | 2022-07-01 |
| Bechon Christian | director: | 2022-06-16 | A-Award | 0 | 2022-06-24 |
| Boilen Scott | director: | 2022-06-16 | A-Award | 0 | 2022-06-24 |
| Herskowitz Neil | director: | 2022-06-16 | A-Award | 0 | 2022-06-24 |